Skip to main content
PLOS One logoLink to PLOS One
. 2023 Oct 5;18(10):e0292182. doi: 10.1371/journal.pone.0292182

Prevalence of HIV testing uptake among the never-married young men (15–24) in sub-Saharan Africa: An analysis of demographic and health survey data (2015–2020)

Emmanuel Musonda 1,*, Million Phiri 1,2, Liness Shasha 1, Chiti Bwalya 3, Shuko Musemangezhi 4, Sage Marie Consolatrice Ishimwe 5, Chester Kalinda 4
Editor: Ephraim Kumi Senkyire6
PMCID: PMC10553359  PMID: 37796957

Abstract

Background

In sub-Saharan Africa, HIV and AIDS remain a major public health concern among adolescents and young men. HIV testing is the first critical step for linking infected individuals to HIV treatment and prevention. However, HIV-testing uptake among sexually active young men remains low in the region. This study was conducted to assess the HIV testing rates among unmarried young men in sub-Saharan Africa.

Methods

Using data from the most recent country Demographic and Health Surveys (DHS) conducted between January 1, 2015, and December 31, 2020, in 18 sub-Saharan African countries, an Inverse Heterogeneity model (IVhet) using MetaXL software was used to estimate country, regional and sub-regional pooled estimates of HIV testing uptake among sexually active unmarried young men in sub-Saharan Africa. Furthermore, multivariable binary logistic regression was conducted to examine the factors associated with HIV testing uptake among unmarried young men.

Results

The overall pooled prevalence estimate of HIV testing uptake among sexually active unmarried young men in sub-Saharan Africa was 33.0% (95% CI: 21–45, I2 = 99%, p <0.001). There was variation in the prevalence across countries ranging from 7% (95% CI: 5–9) in Guinea to 77% (95% CI: 74–80) in Cameroon. Central Africa had the highest prevalence of HIV testing among unmarried young men, at 47% (95% CI:0–100) while West Africa had the lowest prevalence at 11% (95% CI:2–23). Results further show that young men aged 15–19 (aOR = 0.59, 95% CI 0.52–0.66) were less likely to test for HIV. Young men who spent 8 to 12 years in school (aOR = 3.26 95% CI 2.21–4.79) or 13 years and above (aOR = 3.56 95% CI 2.35–5.37) had increased odds of undertaking an HIV test.

Conclusion

The prevalence of HIV testing among sexually active unmarried young men remains low in sub-Saharan Africa. Therefore, the results suggest that health policymakers should consider re-evaluating the current HIV prevention policies and programmes with the view of redesigning the present HIV testing campaigns to enhance the uptake among young people.

Introduction

Emerging evidence suggests that globally, around 37.7 million people are living with HIV and of these, 71% of cases are from sub-Saharan Africa (SSA) [1]. Global efforts into achieving the 95-95-95 goals and United Nations Children’s Fund (UNICEF) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) initiatives have led to increased availability of HIV testing and treatment [2]. Although knowledge of individual serostatus is key in linking infected persons to lifesaving antiretroviral therapy (ART) with a potential reduction in HIV spread, the lag in the number of people testing and knowing their status despite living with HIV remains low; thus increasing the risks of early antiretroviral therapy (ART) initiation [3]. Delayed HIV diagnosis ultimately impacts the initiation of ART leading to severe outcomes, increased morbidity and mortality, and increased HIV transmission [47]. Therefore, understanding the prevalence and factors associated with HIV testing among sexually active unmarried young men would be critical in achieving the 95-95-95 goals and all its initiatives [8, 9].

According to the UNAIDS and UNICEF reports of 2016, SSA has about 2.1 million adolescents living with HIV [10, 11]. Even with the significant progress in voluntary HIV counselling, testing and prevention measures, as well as the introduction of rapid diagnostic tests and self-test delivered through community and home based-strategies, the testing rates among young men remain low across SSA countries [12].

Several studies have highlighted factors that negatively affect the uptake of HIV testing among married or unmarried young men [8, 1318]. At the proximal level, the perception of a low risk of HIV infection, the emotional burden of dealing with a positive result, the absence of support from family and friends, and daily mobility linked to livelihood options, social recreation, and daily mobility to and from school act as barriers [1, 19, 20]. At the distal level, legal barriers such as the age of consent and parental consent laws, health system barriers such as stigma, perceived lack of confidentiality and fear of disrespect by health staff discourage young men from accessing HIV testing services [19].

Significant progress has made towards curbing the HIV pandemic in SSA. However, HIV testing among youths remains a challenge [12]. Although strategies such as HIV self-testing have been developed to reinforce current efforts, several studies conducted in SSA have documented HIV testing among adults and pregnant women, while gaps in the prevalence of HIV testing among adolescents and youths remain unknown [19]. This study was therefore conducted to establish the prevalence of recent HIV testing among sexually active never-married young people 15–24. This information would be very vital in providing decision-makers with evidence to increase HIV-testing coverage, targeting young men [21]. Furthermore, HIV testing data on country and regional disparities would be important to guide the implementation of best practices on sexual and reproductive health [22]. In this study, we applied a meta-analysis to determine the pooled prevalence as well as examine the country and sub-regional heterogeneity of recent HIV testing among unmarried young men 15–24 years in SSA using recent nationally representative data.

Methods and data

Data sources

The data used in this study was extracted from the most recent Demographic and Health Survey (DHS) conducted between 2015 and 2020 in 18 SSA countries. DHS datasets are readily available to the public on the DHS website, https://dhsprogram.com/. Each survey is periodical and population-based, comprising multi-stage stratified samples between 5000 and 30000 people. As a way of enabling comparisons among regions and countries, DHS gathers data using a standardised tool comprising household, women’s, men’s and biomarker questionnaires. In addition, the survey employs a multi-stage stratified design with probabilistic sampling, where each household has an equal chance of selection. Every survey was stratified by rural and urban status and country-specific geographic or administrative regions, such as provinces or regions. An elaborated sampling and data collection plan is available from the survey’s final reports [23].

Study countries

There are 48 countries in SSA. Of the 48 counties, 43 have conducted at least one DHS. Thirty-nine (39) countries had accessible DHS datasets. Of the 39 countries that had accessible DHS data, 18 countries conducted the most recent DHS between 2015 and 2020. Thus, all 18 countries with accessible DHS datasets conducted between 2015 and 2020 were included in the present study. Because some countries did not have latest DHS data, therefore, DHSs conducted between 2015 and 2020 were considered to provide a clear picture of the prevalence of recent HIV testing among sexually active never-married young men in SSA. The sub-regional classification of countries in SSA is based on the United Nations (UN) geo-scheme classification.

Data extraction

The DHS datasets were sourced from the DHS program website, encompassing 18 countries in SSA from 2015 to 2020. The DHS dataset we used for the study contains only data for men aged 15–59 years (MR recode). Our decision to focus our study on unmarried young men was informed by existing literature which shows that unmarried young men are more likely to engage in behaviours that put them at higher risk of HIV infection, such as multiple sexual partners, unprotected sex, or substance use [2427]. Assessing HIV testing rates among young men allows healthcare providers and policymakers to identify gaps in testing coverage and develop targeted interventions to increase testing rates. The extracted information from the country-level datasets comprised the name of the country, year of DHS implementation, weighted sample of the sexually active never-married men aged 15–24 years, counts of sexually active men who underwent an HIV test in the past 12 months before the survey, and sub-region (Table 1).

Table 1. Distribution of sexually active-unmarried young men (15–24) who tested for HIV in the last 12 months preceding the DHS in SSA countries (2015–2020).

Country DHS Year Weighted sample Number of sexually active unmarried men who had recent HIV test Percentage who had an HIV test and received the results Region
Angola 2015 1,574 264 14.6 Southern Africa
Benin 2017 1093 91 7.9 West Africa
Burundi 2016 559 136 23.6 East Africa
Cameroon 2018 645 497 77.5 Central Africa
Chad 2015 527 69 13.8 Central Africa
Ethiopia 2016 788 326 38.8 East Africa
Gambia 2019 78 33 42.6 West Africa
Guinea 2018 595 39 7.2 West Africa
Liberia 2019 752 78 11.7 West Africa
Malawi 2015 1598 661 40.2 Southern Africa
Mali 2018 412 35 7.3 West Africa
Rwanda 2019 492 292 43.4 East Africa
Senegal 2019 783 74 7.2 West Africa
Sierra Leone 2019 194 141 72.9 West Africa
South Africa 2016 873 420 49.3 Southern Africa
Uganda 2016 959 488 49.9 East Africa
Zambia 2018 2564 1370 56.0 Southern Africa
Zimbabwe 2015 1323 517 39.1 Southern Africa

Study measures

Dependent variable

The dependent variable of interest in this study is testing for HIV in the last 12 months before the survey. All sexually active men who were interviewed in the DHS were asked a question on whether they had undertaken an HIV test in the past 12 months prior to the survey. This variable was categorised as a yes or no response. The analysis was restricted to sexually active unmarried young men aged 15–24 years.

Independent variables

Based on the review of existing literature on HIV and AIDS in SSA and elsewhere [13, 18, 2831], the study identified correlates at individual and household levels that could be potentially associated with HIV testing among young men. These variables were classified as socio-economic and demographic. The DHS reference materials and data collection were used to identify the independent variables of interest presented in this section. The following independent variables were included in the study analysis: the age of young men categorised as 15–19, 20–24; total years spent in education was coded as Less than 1 year, 1–7 years, 8–12 years, 13 or more years; wealth index in DHS is usually captured as 5 response categories: poorest, poor, middle, rich, richest. For this study’s analysis, we recoded this variable with the following categorisation: poor, middle and rich; occupation status was categorised as employed, unemployed; age at first sex (15 years, 15 or more); circumcision status (no, yes); number of lifetime sex partners (1 partner, 2–3 partners, 4 or more partners); time since last sexual intercourse in days (less than 30 days, 30 or more days).

Statistical analysis

Statistical analysis was conducted on the pooled dataset comprising 18 DHSs. MetaXL (version 5.3, EpiGear International Pty Ltd, QLD, Australia) was used to perform the descriptive and statistical analysis. The overall prevalence was calculated and its associated 95% confidence interval (CI) for the pooled recent HIV testing among the sexually active unmarried men aged 15–24. Country-specific HIV testing prevalence estimates were computed using the Inverse Heterogeneity (IVhet) model to produce the HIV testing estimates. The IVhet model maintains a correct coverage probability at a lower detected variance. Sub regional pooled prevalence was estimated for (West Africa, Central Africa, East Africa and Southern Africa). The estimated prevalence for individual countries and pooled sub-region was displayed using the forest plot and its associated 95% confidence intervals (CI). The (I2)- statistic was used to quantitatively evaluate the heterogeneity, while the Luis Furuya-Kanamori (LFK) index of the Doi Plot was used to assess the publication bias. Furthermore, a multivariable binary logistic regression model was conducted on pooled data to examine the factors associated with the uptake of HIV testing among unmarried young men in SSA. Sample weights were equalised to give equal weights to each survey included in the analysis.

Ethical approval

The study relied on secondary data sources. Permission to use DHS datasets was obtained from the DHS program. In the DHS data, there are no personal identifiers for survey participants. The original DHS Biomarker and survey protocols for respective countries were approved by the country’s Ethical Review Bodies and the Research Ethics Review Board of the Center for Disease Control and Prevention (CDC) Atlanta. All DHS participants 18 or older were required to consent to interviews. For all participants aged 15 to 17, the DHS policy needed parental/guardian consent before requesting assent from legal minors. Data analysed in this study is available in the public domain (https://dhsprogram.com/).

Results

Study characteristics

A total of 18 SSA DHS datasets were analysed for this study (Table 1). From Central Africa, 2 (11.1%) countries were included (Cameroon, Chad), Eastern Africa had 4 (22.2%) countries included (Burundi, Ethiopia, Rwanda, Uganda) while Southern Africa had 5 (27.8%) countries included (Malawi, Zambia, Zimbabwe, Angola, South Africa), and West Africa had 7 (38.9%) countries included (Benin, Gambia, Liberia, Mali, Senegal, Sierra Leone, Guinea). Our study results show no publication bias because the Luis Furuya-Kanamori index of (-0.45) was within the symmetry range of -1 and +1 (S1 Fig).

Overall pooled prevalence of HIV testing uptake

The pooled prevalence estimate (PPE) for recent HIV testing among unmarried young men from 18 SSA countries was 33.0% (95% CI: 21–45, I2 = 99%, p<0.001). There was variation in the prevalence across countries ranging from 7% (95% CI: 5–9) in Guinea to 77% (95% CI: 74–80) in Cameroon (Fig 1; S1 Table). Only 4 of the 18 countries included in the analysis had a prevalence of recent HIV testing among unmarried young men of 50% or above. These are Cameroon from Central Africa, Uganda from East Africa, Zambia from Southern Africa and Sierra Leone from West Africa (Fig 1).

Fig 1. Prevalence of HIV testing uptake among sexually active unmarried young men aged 15–24 in SSA countries.

Fig 1

Prevalence of HIV testing uptake by sub-region

The pooled prevalence by sub-region showed that Central Africa had the highest prevalence, 47% (95% CI:0–100, I2 = 100, p<0.001) of recent HIV testing among sexually active unmarried young men, whilst West Africa had the lowest prevalence, 11% (95% CI:2–23, I2 = 99, p<0.001) (Table 2).

Table 2. Prevalence of HIV testing uptake among sexually active unmarried young men (15–24) by sub-region.

Region Sample size Prevalence (95%CI) I2 p-value
Central Africa 1,172 0.47 (0.00, 1.00) 100 0.000
East Africa 3,012 0.41 (0.31, 0.52) 97 0.000
Southern Africa 8,744 0.40 (0.26, 0.55) 99 0.000
West Africa 2,814 0.11 (0.02, 0.23) 99 0.000

Determinants of HIV testing uptake among young men

Table 3 presents results from the multivariable regression model showing an association between all independent variables and HIV testing uptake among unmarried young men. Results show that age, years spent in school, household wealth status, occupation, circumcision status, number of lifetime sex partners, and condom use during the last sex with the most recent partner were all factors associated with HIV testing uptake. Young men aged 15–19 (aOR = 0.59; 95% CI: 0.52–0.66) were less likely to test for HIV compared to those aged 20–24. Regarding time spent in education, young men who spent 8 to 9 years (aOR = 3.26; 95% CI: 2.21–4.79) and those who spent 13 years or above (aOR = 3.56; 95% CI: 2.35–5.37) were more likely to test for HIV compared to those who spent less than 1 year in school. Young men who belonged to poor households (aOR = 0.78; 95% CI: 0.67–0.90) were less likely to test for HIV compared to those who were from rich households. Young men who were employed (aOR = 1.14; 95% CI: 1.01–1.30) were more likely to test for HIV compared to the unemployed. Young men who were circumcised were less likely to test for HIV compared to those who were not circumcised (aOR = 0.66; 95% CI: 0.59–0.74).

Table 3. Adjusted odds ratios for the multivariable binary logistic regression of the association between independent variables and HIV testing uptake among sexually young unmarried young men aged 15–24 years in SSA countries.

Background Characteristics (N = 10,122)
Adjusted Odds Ratios p-value (95% CI)
Age  
15–19 0.59 p<0.001 0.52–0.66***
20–24 1  
Total years of education  
Less than 1 1  
1–7 2.15 p<0.001 1.48–3.13***
8–12 3.26 p<0.001 2.21–4.79***
13+ 3.56 p<0.001 2.35–5.37***
Household wealth status  
Poor 0.78 p<0.01 0.67–0.90**
Middle 0.93 p>0.05 0.81–1.08
Rich 1  
Working status  
Unemployed 1  
Employed 1.14 p<0.05 1.01–1.30*
Age at first sex  
Less than15 1  
15 or more 1.15 p>0.05 0.99–1.33
Paid for sex in last 12 months  
No 1  
Yes 0.90 p>0.05 0.76–1.06
Circumcision status  
No 1  
Yes 0.66 p<0.001 0.59–0.74***
Number of lifetime sex partners  
1 1  
2–3 1.16 p<0.05 1.01–1.33*
4+ 1.30 p<0.01 1.10–1.52**
Time since last sexual intercourse in days  
Less than 30 days 1  
30 or more days 0.63 p>0.05 0.39–1.04
Used condom during last sex with most recent partner  
No 1  
Yes 1.58 p<0.05 1.41–1.77***
Sexual activity in past 4 weeks  
No 1
Yes 0.69 p>0.05 0.42–1.13

*** = p < 0.001

** = p < 0.01

* = p < 0.05

Discussion

This study was conducted using DHS data for 18 countries to determine the prevalence and examine the factors associated with HIV testing among the never-married young men aged 15–24 years in SSA. The study results show that the pooled prevalence of HIV testing among the never-married young men is still low, 32% (95% CI: 21,44). A study conducted by Asaolu and others in 2016 reported a prevalence of 23% among young people in SSA [14]. The results show that Cameroon had the highest proportion of HIV testing among never-married young men, 77% (95% CI: 74,80) while Guinea had the lowest proportion of HIV testing uptake among the never-married young men at 7% (95% CI: 5,9). A study conducted by Staveteig and others in 2013 reported that Malawi had the highest proportion of youths 20–24 years (84%) who tested for HIV and the least prevalence was reported in Chad at 1% [32].

HIV testing rates varied across sub-regions in SSA. Central Africa showed the highest prevalence, 47% whilst West Africa had the lowest prevalence at 11%. This result is partly similar to what was reported by a previous study conducted by Asaolu and others in 2016, which showed that Eastern Africa (78%) had the highest proportion of youths that tested for HIV and the least was Western Africa (31%) [14]. One reason for the variation in HIV testing across countries and regions could be variations in HIV policy and policy programme implementation across countries [33]. Additionally, differences in sociocultural values and beliefs could also contribute to variations in acceptance of HIV testing among young people [3437]. For instance, Malawi has been particularly advanced in promoting the rapid initiation of antiretroviral therapy [38].

The information about the pooled prevalence of HIV testing among sexually unmarried young men in SSA is essential for designing HIV programmes, taking into consideration specificities that may be related to the age group [12]. The results from this current study show that the prevalence of HIV testing among young men remains low in SSA. This has the potential to increase the risk of not achieving the UNAIDS “95-95-95” initiative [20]. Therefore, there is a need to identify and scale up strategies that enhance HIV diagnosis and to have infected young people start treatment at much higher than current CD4 counts [39]. Despite the progress in terms of strategy and policy to improve access to HIV services, a huge disparity exists in terms of the prevalence of HIV testing among SSA countries exists. One way for the future global response to HIV is sustained donor funding accompanied by innovative financing and strategic redeployment of health system assets to ensure that the delivery of HIV services is resilient and sustainable [40].

Our study further found that age, number of years spent in school, wealth index, occupation, circumcision status, number of lifetime sex partners, and condom use were significantly associated with HIV testing among unmarried young men (15–24) in SSA. In this current analysis, young men aged 15–19 years were less likely to test for HIV. Studies conducted elsewhere support these findings [14, 35, 41]. One explanation for this could be the fact that many young people rarely receive thorough sexuality education and are less aware of the health hazards connected with HIV. This makes them less knowledgeable about the value of routine HIV testing and the advantages of early detection [42, 43].

Several studies have reported the association between education with HIV testing in SSA [4446]. A similar finding from our study revealed that an increase in the number of years spent in school increases the likelihood of testing for HIV. This implies that education is essential for boosting knowledge and understanding of HIV transmission, prevention, and the value of routine testing. People with higher levels of education are more likely to have access to reliable information and comprehend the risks connected with HIV, which promotes a better feeling of personal responsibility for one’s health [9, 47]. Second, socioeconomic status and education are frequently correlated, and this can facilitate access to healthcare services, including HIV testing. People who are more educated might have access to superior financial resources, health insurance coverage, and knowledge of nearby medical facilities, making it simpler for them to get tested for HIV [46, 48].

Young men belonging to poor households had lower odds of testing for HIV in SSA. This finding supports the conclusion of a previous study, which showed that belonging to poor households is associated with low HIV testing [8]. One explanation could be that people from low-income households frequently encounter obstacles while trying to get healthcare services, such as HIV testing. People may choose not to get tested for HIV because of a lack of money, a lack of health insurance, or a long commute to a hospital [32, 49].

This study has provided useful findings that have the potential to inform the strengthening of existing HIV prevention programmes tareting young people. Enhancing uptake of HIV testing among young people will play a vital role in reducing the risk of acquiring HIV among adolescents and young men hence optimising their health and well-being [50]. HIV testing uptake among young people can be improved by enhancing deferential HIV programming activities and encouraging self HIV-testing strategies that overcome obstacles such as stigmatisation and discrimination [30]. Furthermore, increasing awareness, acceptance, and support for age-specific sexuality health education campaigns need to be enhanced to improve HIV-testing uptake.

Limitations of the study

The study has provided a comprehensive picture of the prevalence of HIV testing rates and factors associated with the uptake of HIV testing among sexually active young people in SSA. However, there are limitations to the study. First, not all SSA countries were analysed because most countries have DHS data collected before 2015. Therefore, the findings in this study would be generalised only to the group of countries considered in the analysis. Second, the surveys used in our analysis were not conducted during the same period, thus the pooled prevalence reported covers the period 2015 to 2020. Last, the DHS collects information for events that happened prior to the data collection exercise, therefore, data may suffer from recall bias. Despite these limitations, the DHS provides useful national-level health indicators which can inform the design of targeted public health policies and interventions aimed at reducing the risk of HIV infections among young people in SSA.

Conclusion

The study has established that HIV testing uptake among sexually active unmarried young men in SSA is low. There are significant variations in HIV testing uptake across countries and sub-regions. Age, number of years spent in education, employment status, male circumcision status and number of sexual partners were associated with HIV testing uptake among young men. The study findings imply that investing in education sector to increase access among young people has the potential to increase the uptake of HIV testing. The findings may suggest the need for improved implementation of age-specific social behaviour change activities to enhance HIV testing uptake among sexually active young men. Building on past successful best practices, HIV policies and programmes and blending them with new strategies would be essential in increasing HIV testing uptake among young men. There is a need for further research to understand best practices regarding sexual and reproductive health and HIV prevention programming from better-performing countries.

Supporting information

S1 Fig. Doi plot show publication measure of bias for the studies included.

(DOCX)

S1 Table. Sensitivity analysis results.

(DOCX)

Acknowledgments

We appreciate the Demographic and Health Survey Program, ICF and other partners involved in the DHS program.

List of abbreviations

AIDS

Acquired Immune Deficiency Syndrome

CI

Confidence Interval

DHS

Demographic and Health Survey

EA

Enumeration Area

HIV

Human Immunodeficiency Virus

SDG

Sustainable Development Goal

SRH

Sexual Reproductive Health

SSA

Sub-Saharan Africa

UNFPA

United Nations Population Fund

UNICEF

United Nations Children Fund

USAID

United States Aid for International Development

WHO

World Health Organisation

ZDHS

Zambia Demographic and Health Survey

Data Availability

Data used in our study is publicly available at DHS program website (https://dhsprogram.com/).

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.UNAIDS. Young people and HIV. Geneva: U N Join Programme HIVAIDS 2020. 2021;20. [Google Scholar]
  • 2.UNAIDS. 2020 Global AIDS Update ⁠—Seizing the moment ⁠—Tackling entrenched inequalities to end epidemics. 2020;384. [Google Scholar]
  • 3.Albert J, Berglund T, Gisslén M, Gröön P, Sönnerborg A, Tegnell A, et al. Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy. Scand J Infect Dis. 2014. Oct;46(10):673–7. doi: 10.3109/00365548.2014.926565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. N Engl J Med. 2011. Aug 11;365(6):493–505. doi: 10.1056/NEJMoa1105243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014. Apr;14(4):281–90. doi: 10.1016/S1473-3099(13)70692-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012. Apr 24;26(7):893–6. doi: 10.1097/QAD.0b013e328351f73f [DOI] [PubMed] [Google Scholar]
  • 7.Phiri M. AWARENESS, KNOWLEDGE, ATTITUDES AND UP-TAKE OF MALE CIRCUMCISION AS AN HIV PREVENTION STRATEGY AMONG YOUTH IN ZAMBIA: A CASE STUDY OF LUSAKA DISTRICT. Univ Zamb. 2011;74. [Google Scholar]
  • 8.Heri AB, Cavallaro FL, Ahmed N, Musheke MM, Matsui M. Changes over time in HIV testing and counselling uptake and associated factors among youth in Zambia: a cross-sectional analysis of demographic and health surveys from 2007 to 2018. BMC Public Health. 2021. Dec;21(1):456. doi: 10.1186/s12889-021-10472-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jooste S, Mabaso M, Taylor M, North A, Tadokera R, Simbayi L. Trends and determinants of ever having tested for HIV among youth and adults in South Africa from 2005–2017: Results from four repeated cross-sectional nationally representative household-based HIV prevalence, incidence, and behaviour surveys. Fischer F, editor. PLOS ONE. 2020. May 14;15(5):e0232883. doi: 10.1371/journal.pone.0232883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.UNAIDS. Ending the AIDS epidemic for adolescents, with adolescents. Geneva Switz. 2016d;32.
  • 11.UNICEF. Every three minutes a teenage girl is infected by HIV–UNICEF [Internet]. 2018 [cited 2022 Aug 21]. Available from: https://www.unicef.org/wca/press-releases/every-three-minutes-teenage-girl-infected-hiv-unicef
  • 12.Sharma M, Ying R, Tarr G, Barnabas R. Systematic review and meta-analysis of community and facility-based HIV testing to ad- dress linkage to care gaps in sub-Saharan Africa. 2021;9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Allegri MD, Agier I, Tiendrebeogo J, Louis VR, Yé M, Mueller O, et al. Factors Affecting the Uptake of HIV Testing among Men: A Mixed-Methods Study in Rural Burkina Faso. PLOS ONE. 2015. Jul 1;10(7):e0130216. doi: 10.1371/journal.pone.0130216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Asaolu IO, Gunn JK, Center KE, Koss MP, Iwelunmor JI, Ehiri JE. Predictors of HIV Testing among Youth in Sub-Saharan Africa: A Cross-Sectional Study. Thorne C, editor. PLOS ONE. 2016. Oct 5;11(10):e0164052. doi: 10.1371/journal.pone.0164052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hlongwa M, Mashamba-Thompson T, Makhunga S, Hlongwana K. Barriers to HIV testing uptake among men in sub-Saharan Africa: a scoping review. Afr J AIDS Res. 2020. Jan 2;19(1):13–23. doi: 10.2989/16085906.2020.1725071 [DOI] [PubMed] [Google Scholar]
  • 16.Leta TH, Sandøy IF, Fylkesnes K. Factors affecting voluntary HIV counselling and testing among men in Ethiopia: a cross-sectional survey. BMC Public Health. 2012. Jun 15;12(1):438. doi: 10.1186/1471-2458-12-438 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mandiwa C, Namondwe B. Uptake and correlates of HIV testing among men in Malawi: evidence from a national population–based household survey. BMC Health Serv Res. 2019. Mar 29;19(1):203. doi: 10.1186/s12913-019-4031-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Phiri M, Lemba M, Chomba C, Kanyamuna V. Examining differentials in HIV transmission risk behaviour and its associated factors among men in Southern African countries. Humanit Soc Sci Commun. 2022. Aug 27;9(1):1–12. doi: 10.1057/s41599-022-01312-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Chowdhury MZI, Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Fam Med Community Health. 2020. Feb;8(1):e000262. doi: 10.1136/fmch-2019-000262 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.UNAIDS. Global AIDS Strategy 2021–2026—End Inequalities. End AIDS. 2021;164. [Google Scholar]
  • 21.Mason S, Ezechi OC, Obiezu-Umeh C, Nwaozuru U, BeLue R, Airhihenbuwa C, et al. Understanding factors that promote uptake of HIV self-testing among young people in Nigeria: Framing youth narratives using the PEN-3 cultural model. Lu X, editor. PLOS ONE. 2022. Jun 3;17(6):e0268945. doi: 10.1371/journal.pone.0268945 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.WHO. IMPROVING MEN’S UPTAKE OF HIV TESTING AND LINKAGE TO SERVICES [Internet]. Geneva: World Health Organization.; 2021. Available from: https://apps.who.int/iris/rest/bitstreams/1332493/retrieve [Google Scholar]
  • 23.Croft TN, Marshall AM, Allen CK, Arnold F, Assaf S, Balian S. Guide to DHS Statistics. [Internet]. Rockville, MD: ICF.; 2018. Available from: https://dhsprogram.com/ [Google Scholar]
  • 24.Diress G, Adane S, Linger M, Merchaw A, Mengist B. Individual and community-level determinates of risky sexual behaviors among sexually active unmarried men: A multilevel analysis of 2016 Ethiopian Demographic and Health Survey. Hensel DJ, editor. PLOS ONE. 2022. Jul 21;17(7):e0270083. doi: 10.1371/journal.pone.0270083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Biney E, Ewemooje OS, Amoateng AY. Predictors of sexual risk behaviour among unmarried persons aged 15–34 years in South Africa. Soc Sci J. 2022. Oct 2;59(4):543–58. [Google Scholar]
  • 26.Berhan Y, Berhan A. A Meta-Analysis of Risky Sexual Behaviour among Male Youth in Developing Countries. AIDS Res Treat. 2015;2015:1–9. doi: 10.1155/2015/580961 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sharma SK, Vishwakarma D. Transitions in adolescent boys and young Men’s high-risk sexual behaviour in India. BMC Public Health. 2020. Dec;20(1):1089. doi: 10.1186/s12889-020-09191-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bekele YA, Fekadu GA. Factors associated with HIV testing among young females; further analysis of the 2016 Ethiopian demographic and health survey data. Torpey K, editor. PLOS ONE. 2020. Feb 11;15(2):e0228783. doi: 10.1371/journal.pone.0228783 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kalibbala D, Mpungu SK, Ssuna B, Muzeyi W, Mberesero H, Semitala FC, et al. Determinants of testing for HIV among young people in Uganda. A nested, explanatory-sequential study. Amponsah-Dacosta E, editor. PLOS Glob Public Health. 2022. Dec 5;2(12):e0000870. doi: 10.1371/journal.pgph.0000870 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kabeta T, Belina M, Nigatu M. HIV Voluntary Counseling and Testing Uptake and Associated Factors Among Sexually Active Men in Ethiopia: Analysis of the 2016 Ethiopian Demographic and Health Survey Data. HIVAIDS—Res Palliat Care. 2020. Aug;Volume 12:351–62. doi: 10.2147/HIV.S263851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Muchimba M, Zyambo C. Characteristics and Sexual Risk Behavior of Men Who Never Tested for HIV in Zambia. Am J Mens Health. 2021. Nov 1;15(6):15579883211063344. doi: 10.1177/15579883211063343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Staveteig S, Croft TN, Kampa KT, Head SK. Reaching the ‘first 90’: Gaps in coverage of HIV testing among people living with HIV in 16 African countries. Graham SM, editor. PLOS ONE. 2017. Oct 12;12(10):e0186316. doi: 10.1371/journal.pone.0186316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Church K, Kiweewa F, Dasgupta A, Mwangome M, Mpandaguta E, Gómez-Olivé FX, et al. A comparative analysis of national HIV policies in six African countries with generalized epidemics. Bull World Health Organ. 2015. Jul 1;93(7):457–67. doi: 10.2471/BLT.14.147215 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Motshegwa GD, Palamuleni ME. Determinants of HIV testing among young people in South Africa | Gender and Behaviour [Internet]. 2020. [cited 2022 Aug 23]. Available from: https://www.ajol.info/index.php/gab/article/view/203477 [Google Scholar]
  • 35.Sonko I, Chung MH, Hou WH, Chen WT, Chang PC. Predictors of HIV testing among youth aged 15–24 years in The Gambia. PLoS ONE. 2022. Feb 18;17(2):e0263720. doi: 10.1371/journal.pone.0263720 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Seidu AA. Using Anderson’s Model of Health Service Utilization to Assess the Use of HIV Testing Services by Sexually Active Men in Ghana. Front Public Health. 2020;8:512. doi: 10.3389/fpubh.2020.00512 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.UNAIDS. HIV and AIDS in East and Southern Africa regional overview. 2020;20. [Google Scholar]
  • 38.Agha S. Factors associated with HIV testing and condom use in Mozambique: implications for programs. Reprod Health. 2012. Dec;9(1):20. doi: 10.1186/1742-4755-9-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Nash D, Yotebieng M, Sohn AH. Treating all people living with HIV in sub-Saharan Africa: a new era calling for new approaches. J Virus Erad. 2018. Nov;4:1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.United Nations Children’s Funds. 2022-EB2-HIV-AIDS-EN-2022.01.05.pdf [Internet]. 2022 [cited 2022 May 21]. Available from: https://www.unicef.org/executiveboard/media/8791/file/2022-EB2-HIV-AIDS-EN-2022.01.05.pdf
  • 41.Worku MG, Teshale AB, Tesema GA. Prevalence and associated factors of HIV testing among young (15–24) women in eastern Africa: a multilevel analysis of demographic health survey data (2008–2018). Arch Public Health. 2022. Dec;80(1):117. doi: 10.1186/s13690-022-00879-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Jung MS, Dlamini NS, Cui X, Cha K. Prevalence of HIV testing and associated factors among young adolescents in Eswatini: a secondary data analysis. BMC Pediatr. 2022. Nov 14;22(1):659. doi: 10.1186/s12887-022-03698-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Giguère K, Eaton JW, Marsh K, Johnson LF, Johnson CC, Ehui E, et al. Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000–20: a modelling study using survey and HIV testing programme data. Lancet HIV. 2021. May;8(5):e284–93. doi: 10.1016/S2352-3018(20)30315-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Baisley K, Chimbindi N, Mthiyane N, Floyd S, McGrath N, Pillay D, et al. High HIV incidence and low uptake of HIV prevention services: The context of risk for young male adults prior to DREAMS in rural KwaZulu-Natal, South Africa. Laga M, editor. PLOS ONE. 2018. Dec 26;13(12):e0208689. doi: 10.1371/journal.pone.0208689 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Peltzer K, Matseke G. Determinants of HIV testing among young people aged 18–24 years in South Africa. Afr Health Sci. 2014. Feb 11;13(4):1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Somefun OD, Wandera SO, Odimegwu C. Media Exposure and HIV Testing Among Youth in Sub-Saharan Africa: Evidence From Demographic and Health Surveys (DHS). SAGE Open. 2019. Apr 1;9(2):2158244019851551. [Google Scholar]
  • 47.Qiao S, Zhang Y, Li X, Menon JA. Facilitators and barriers for HIV-testing in Zambia: A systematic review of multi-level factors. Yotebieng M, editor. PLOS ONE. 2018. Feb 7;13(2):e0192327. doi: 10.1371/journal.pone.0192327 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Musumari PM, Tangmunkongvorakul A, Srithanaviboonchai K, Yungyuankul S, Techasrivichien T, Suguimoto SP, et al. Prevalence and Correlates of HIV Testing among Young People Enrolled in Non-Formal Education Centers in Urban Chiang Mai, Thailand: A Cross-Sectional Study. Newman PA, editor. PLOS ONE. 2016. Apr 12;11(4):e0153452. doi: 10.1371/journal.pone.0153452 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Garcia-Codina O, Juvinyà-Canal D, Amil-Bujan P, Bertran-Noguer C, González-Mestre MA, Masachs-Fatjo E, et al. Determinants of health literacy in the general population: results of the Catalan health survey. BMC Public Health. 2019. Dec;19(1):1122. doi: 10.1186/s12889-019-7381-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Treves-Kagan S, El Ayadi AM, Pettifor A, MacPhail C, Twine R, Maman S, et al. Gender, HIV Testing and Stigma: The Association of HIV Testing Behaviors and Community-Level and Individual-Level Stigma in Rural South Africa Differ for Men and Women. AIDS Behav. 2017. Sep;21(9):2579–88. doi: 10.1007/s10461-016-1671-8 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Ephraim Kumi Senkyire

22 May 2023

PONE-D-23-03270HIV testing rates among the never-married young men in sub-Saharan Africa: an analysis of Demographic and Health Survey data (2010-2020)PLOS ONE

Dear Dr. Musonda,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 06 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ephraim Kumi Senkyire

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please upload a copy of Figure 1, to which you refer in your text on page 9. If the figure is no longer to be included as part of the submission please remove all reference to it within the text.

3.PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ.

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The work seeks to access the HIV testing rate among unmarried young men in SSA. It was well written. However, there are some concerns that you need to address

1. The aim of the study was not well stated.

2. Why was this study restricted to young unmarried men? Why did you exclude young unmarried women? Why did you also exclude married men and women? This was not explained in the manuscript.

3. How were the countries selected? Those excluded why were they excluded?

4. The discussion was poorly written. You did not relate it to other literatures on HIV testings among young unmarried men elsewhere. You did not give a possible reason for your findings and how it compared to findings elsewhere.

5. Though, you mentioned in your limitation section that the data were collected at different years and may have been collected earlier than published, how did you ensure that despite this disparity, the data could be compared without bias? Are you sure the situation has not changed in some of the countries?

Reviewer #2: The title does not read well and should be revised. The third paragraph of the discussion needs to be revised. Some of the information presented in the introduction and discussion seems assumptive and needs to be substantiated with literature. Additional data collection (other data sets) and analysis would be helpful in deriving more sound conclusions and suggested changes to policy that would be both realistic and sustainable. Acknowledgement of the range of data spanning a substantial time period (2010-2022) as a limitation was noteworthy but this does pose a problem to the accuracy of the analysis. Perhaps the data should be limited to a smaller time window as advances in HIV diagnosis, research and therapeutics have occurred at a rapid rate within the past 20 years. Furthermore, due to certain countries within SSA not have accessible DHS datasets this could possibly not be an accurate representation of SSA. This being said, the study does make use of good data analysis techniques and draws some important conclusions which may influence healthcare policies. Additional suggestions/recommendations could be helpful in this regard.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Tijani Idris Ahmad Oseni

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Ephraim Kumi Senkyire

10 Jul 2023

PONE-D-23-03270R1Prevalence of HIV testing among the never-married young men (15-24) in sub-Saharan Africa: an analysis of Demographic and Health Survey data (2015-2022)PLOS ONE

Dear Dr. Musonda,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 24 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please indicate  in your response with reference to number line(s) in the manuscripts where reviewers comments were addressed. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ephraim Kumi Senkyire

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear Author

for your manuscripts to be accepted, you need to provide point by point with reference to number line (s) in manuscript to reviewers comments . your Reponses to the reviewers can not be verified in the manuscript hence you need to indicate the number line(s) where to corrections were made

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Tijani Oseni

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

Ephraim Kumi Senkyire

17 Jul 2023

PONE-D-23-03270R2Prevalence of HIV testing among the never-married young men (15-24) in sub-Saharan Africa: an analysis of Demographic and Health Survey data (2015-2022)PLOS ONE

Dear Dr. Musonda,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

My comment(s) were not addressed hence respond to it appropriately  before final decision can be made.

Please submit your revised manuscript by Aug 31 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ephraim Kumi Senkyire

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Hello

I asked in my previous message for you to address reviewers comment point by pint indicating the corresponding number line(s) however this was not done hence you need to to that.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Oct 5;18(10):e0292182. doi: 10.1371/journal.pone.0292182.r006

Author response to Decision Letter 2


30 Jul 2023

Dear Editor,

Thank you for your guidance. We have updated the rebuttal letter to ensure that each of the reviewer's comments is addressed point by point indicating the corresponding number line(s) where the changes or edits have been made in the manuscript document We have also highlighted the said changes in the manuscript document. Looking forward to your further guidance.

Regards,

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 3

Ephraim Kumi Senkyire

7 Aug 2023

PONE-D-23-03270R3Prevalence of HIV testing among the never-married young men (15-24) in sub-Saharan Africa: an analysis of Demographic and Health Survey data (2015-2022)PLOS ONE

Dear Dr. Musonda,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Thank you for your responses however few corrections need to be done:

1. reference(s) is/are need for your reasons to include only unmarried men......

2.line 108: in your feedback to the reviewer, you indicted that a total of 19 countries were included however, in the manuscript you indicated 18 countries.  this discrepancy need to be resolved. 

==============================

Please submit your revised manuscript by Sep 21 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ephraim Kumi Senkyire

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Thank you for your responses however few corrections need to be done:

1. reference(s) is/are need for your reasons to include only unmarried men......

2.line 108: in your feedback to the reviewer, you indicted that a total of 19 countries were included however, in the manuscript you indicated 18 countries. this discrepancy need to be resolved.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Oct 5;18(10):e0292182. doi: 10.1371/journal.pone.0292182.r008

Author response to Decision Letter 3


28 Aug 2023

Dear Editor,

Thank you for your guidance. We have updated the rebuttal letter to address the editors comments. We have also highlighted the said changes in the manuscript document. Looking forward to your further guidance.

Regards,

Attachment

Submitted filename: Reviewers Response.docx

Decision Letter 4

Ephraim Kumi Senkyire

14 Sep 2023

Prevalence of HIV testing among the never-married young men (15-24) in sub-Saharan Africa: an analysis of Demographic and Health Survey data (2015-2020)

PONE-D-23-03270R4

Dear Dr. Musonda,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ephraim Kumi Senkyire

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Ephraim Kumi Senkyire

28 Sep 2023

PONE-D-23-03270R4

Prevalence of HIV testing uptake among the never-married young men (15-24) in sub-Saharan Africa: an analysis of Demographic and Health Survey data (2015-2020)

Dear Dr. Musonda:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof Ephraim Kumi Senkyire

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Doi plot show publication measure of bias for the studies included.

    (DOCX)

    S1 Table. Sensitivity analysis results.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Rebuttal letter.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Reviewers Response.docx

    Data Availability Statement

    Data used in our study is publicly available at DHS program website (https://dhsprogram.com/).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES